Answers are grounded in this paper and cite their sources.
Dengue fever is a mosquito-borne viral disease. Female Aedes aegypti mosquitoes play the main role in the transmission of this infection. In 1964, the first dengue fever outbreak occurred sporadically in Bangladesh, which was then known as Dacca fever. However, this country experienced its severe form, dengue hemorrhagic fever (DHF), as an epidemic in 2000.[1,2] Outbreaks of dengue fever are climate-dependent, usually occurring during warmer months and the monsoon season (April–September).[3] The incidence of dengue fever is increasing exponentially. In 2000, half a million people were infected, but this number increased eightfold and became two billion in 2022.[4] According to the Director General of Health Services (DGHS) health emergency and control room source (October 2, 2023), Bangladesh experienced a dreadful epidemic in 2023 with about 225,000were confirmed cases and more than 1000 people died. About 38,000 children up to 15 years of age were infected, and 113 children died from dengue fever.[5] Dengue was only confined to Dhaka city from 2000 to 2018, but since 2019, it spread to different cities of Bangladesh. The last epidemic occurred in 2023 and showed its devastating effects in rural areas as well.[6] So, Dengue outbreaks are no longer confined to specific geographical areas in Bangladesh. Global warming and climate change are held responsible by experts for this changing trend of dengue. The high temperatures broke previous records in Bangladesh in 2023, and Dhaka experienced its highest temperature this year, which is an important factor behind this deadly outbreak. This year’s outbreak was caused by DENV2 and DENV3 strains of the dengue virus.[3] Similar to previous years, people with repeated infections faced more complications. Dengue fever is a flu-like disease, usually presenting with fever, headache, bone pain, and malaise. But this year, children with dengue fever were presented with vomiting, abdominal pain, less urine output, and complications such as shock, bleeding manifestations, and neurological manifestations at a very early stage of the disease. Concomitant infections such as enteric fever, viral hepatitis, diarrhea, respiratory tract infection, and urinary tract infections change the pattern of signs and symptoms, leading to more complications. The mainstay of treatment of dengue infection is fluid management. This concept was not developed at the beginning of the century, in the year 2000. At that time, more focus was on platelet or blood transfusions and antibiotic therapy rather than on meticulous fluid management. So, we faced a great failure in saving the lives of some children with dengue fever. On top of that, these interventions proved unnecessary and sometimes harmful.[7] Preparation was not enough to fight that outbreak. By taking lessons from that epidemic, we have started to prepare ourselves to combat the epidemic of dengue since the beginning of year 2001. Different training programs and guidelines were aimed at establishing a standard treatment regimen through government initiatives and the assistance of the World health organization. We analyze dengue thoroughly and try to learn about different management protocols for dengue patients. By different studies it is proven that proper fluid management is the cornerstone of dengue treatment. The modalities of fluid management would differ in various dengue situations. Simple dengue fever can be managed by only taking adequate oral fluid, but DHF and dengue shock syndrome (DSS) must be managed in the hospital with meticulous follow-up and appropriate intravenous (IV) fluid. Antibiotics and steroids do not have a role in dengue patients, with some exceptions. However, this year, many children were presented with concomitant bacterial infections, which were proven by laboratory investigations. Different antibiotics were required for the management of these children. Otherwise, it is always discouraged to give antibiotics for isolated dengue infection. Some laboratory profiles, such as total count, hematocrit (Hct), and platelet count, can be used to predict the prognosis of dengue patients.[8] After the year 2000, the trend of dengue fever remained similar up to 2017, with preparations for managing dengue cases during the monsoon and post-monsoon seasons. However, reemergence of DENV3 in circulation made the incident rates of dengue fever higher from 2018 onwards. The combined initiatives and efforts made by government and nongovernment bodies in Bangladesh made it possible to take on the dengue epidemic. In the meantime, we fought against the COVID-19 pandemic successfully with efforts from every level of the health sector, and the number of casualties was minimal due to dengue. Our satisfaction did not sustain for long. Dengue fever came back with its devastating power in the whole country. The highest number of infected cases, along with the highest mortality rate, made all our efforts pointless. The sudden rise in incidence produced a temporary crisis in the supply of IV fluid and necessary equipment. The government took rapid action to solve the scarcity of required fluids, opening dengue corners in various hospitals and ensuring supply of dengue diagnostic kits free of cost in public sectors and at minimum rates in private sectors. The tremendous efforts of our doctors, nurses, technicians, and other health professionals cannot be overlooked. Working day and night without any holiday made victory in the war against this deadly outbreak possible ultimately. Some of the health workers paid the debt to the country, giving their lives during this fight. During the management of dengue fever, we must give priority to children because of the following factors:[9-14] Children have underdeveloped immune systems, which make them more prone to infection without classical signs and symptoms and may associate with concomitant infections. Irritability, changing patterns of appetite, and sleep may be the signs of dengue infection. The water content of the body of a child is much higher than that of an adult, with a higher proportion of extracellular fluid. A child has relatively more body surface area than adults. A child has a much higher metabolic rate than an adult. Due to these factors, children are at more risk of developing DHF and DSS. So, adequate fluid administration can save the children from morbidity and mortality caused by dengue infection. Oral fluid intake should be encouraged in mild cases, but IV fluid is recommended for moderate to severe cases. For younger children (age < 6 months), 0.45% sodium chloride is recommended as IV fluid in recent guidelines, whereas isotonic fluids like normal saline, Ringer’s lactate, or Hartman’s solution are recommended for others. Fluid should be started with 5–7 mL/kg/h for 1–2 h, then reduced to 3–5 mL/kg/h for 2-4 h, and then reduced to 2–3 mL/kg/h or less according to clinical response. Management of shock with isotonic crystalloid solution at 5–10 mL/kg/h over 1 h should be a priority in all children with DSS.[8] Children should be monitored meticulously through clinical and hematological parameters. Pulse volume, blood pressure, and urine output are important clinical parameters to see the response of patients to fluid management. In case of children, appropriate size of cuff should be used to ensure accurate measurement of blood pressure. Previously, everybody was concerned about platelet count during management of dengue fever. The current guidelines on dengue management give emphasis on Hct monitoring during fluid resuscitation. A 20% increase of Hct from baseline gives a warning of plasma leakage and is an indication for increasing the rate of IV fluid. Platelet infusion without some specific indications is discouraged in recent protocols for management of dengue.[8] In Bangabandhu Shaikh Mujib medical university (BSMMU), more than 1000 children with dengue were admitted and managed during the outbreak in 2023. This time, one patient developed hemophagocytic lymphohistiocytosis (HLH), and one patient developed neurological complications. Many children came with low-grade fever with features of hypovolemia on day 2 of illness and were managed as DHF and DSS. Though the outbreak was a deadly episode, there was no mortality among children with dengue fever in BSMMU. In the outbreak in 2019, 95.5% of children with dengue fever presented with fever, and only 18.2% of febrile children developed DSS in BSMMU. Other predominant symptoms and signs were abdominal pain, respiratory distress, bleeding, positive tourniquet test, shock, edema, ascites, and hepatomegaly.[15] No neurological complications were documented in that period. However, in 2023, one child with dengue fever had a neurological complication in BSMMU. Prevention of dengue in Bangladesh cannot be possible solely on the efforts of the government. Various combined activities taken by government and nongovernment organizations should be implemented to raise public awareness and participation, maintaining environmental cleanliness, vector control, and preparing the health sector for further outbreaks with proper equipment. Recently, a dengue vaccine named TV005 was successfully trialed on 200 volunteers aged between 1 and 49 years under the supervision of international center for diarrhoeal disease research, Bangladesh and University of Vermont, vaccine testing center.[16] It is expected that a single dose of this vaccine will protect our children from all existing serotypes of dengue virus. This revolutionary intervention will show the right path to prevent and control dengue infections in Bangladesh and enlighten our health sector with a new hope of pursuing victory against dengue infection. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Mutanabbi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: